Sangamo Therapeutics
SGMO
SGMO
111 hedge funds and large institutions have $408M invested in Sangamo Therapeutics in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
12% more funds holding
Funds holding: 99 → 111 (+12)
Holders
111
Holding in Top 10
3
Calls
$82.4M
Puts
$5.11M
Top Buyers
| 1 | +$24.4M | |
| 2 | +$17.7M | |
| 3 | +$15.6M | |
| 4 |
Goldman Sachs
New York
|
+$11.5M |
| 5 |
PA
Perceptive Advisors
New York
|
+$10.1M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$5.88M | |
| 3 | -$2.5M | |
| 4 |
Morgan Stanley
New York
|
-$2.06M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.74M |